Sanofi SA's Fiscal Year is From January To December - All Figures are in Days.
The item "Defensive-Intrval-Ratio" stands at 145.03 days as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Defensive Intrval Ratio" stands at 145.03 Days. This represents a decrease of -59.59 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.41 percent compared to the value the year prior.
The 1 year change in percent is 19.41.
The 3 year change in percent is 29.38.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Defensive Intrval Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Defensive Intrval Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Defensive Intrval Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Defensive Intrval Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Defensive Intrval Ratio | 280,205,508,085.11 |